Literature DB >> 25360794

Circular trimers of gelatinase B/matrix metalloproteinase-9 constitute a distinct population of functional enzyme molecules differentially regulated by tissue inhibitor of metalloproteinases-1.

Jennifer Vandooren1, Benjamin Born2, Inna Solomonov2, Ewa Zajac3, Radka Saldova4, Michael Senske2, Estefanía Ugarte-Berzal5, Erik Martens1, Philippe E Van den Steen1, Jo Van Damme6, Angeles Garcia-Pardo5, Matheus Froeyen7, Elena I Deryugina3, James P Quigley3, Søren K Moestrup8, Pauline M Rudd4, Irit Sagi2, Ghislain Opdenakker1.   

Abstract

Gelatinase B/matrix metalloproteinase-9 (MMP-9) (EC 3.4.24.35) cleaves many substrates and is produced by most cell types as a zymogen, proMMP-9, in complex with the tissue inhibitor of metalloproteinases-1 (TIMP-1). Natural proMMP-9 occurs as monomers, homomultimers and heterocomplexes, but our knowledge about the overall structure of proMMP-9 monomers and multimers is limited. We investigated biochemical, biophysical and functional characteristics of zymogen and activated forms of MMP-9 monomers and multimers. In contrast with a conventional notion of a dimeric nature of MMP-9 homomultimers, we demonstrate that these are reduction-sensitive trimers. Based on the information from electrophoresis, AFM and TEM, we generated a 3D structure model of the proMMP-9 trimer. Remarkably, the proMMP-9 trimers possessed a 50-fold higher affinity for TIMP-1 than the monomers. In vivo, this finding was reflected in a higher extent of TIMP-1 inhibition of angiogenesis induced by trimers compared with monomers. Our results show that proMMP-9 trimers constitute a novel structural and functional entity that is differentially regulated by TIMP-1.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 25360794      PMCID: PMC4399976          DOI: 10.1042/BJ20140418

Source DB:  PubMed          Journal:  Biochem J        ISSN: 0264-6021            Impact factor:   3.857


  54 in total

1.  Identification of CD63 as a tissue inhibitor of metalloproteinase-1 interacting cell surface protein.

Authors:  Ki-Kyung Jung; Xu-Wen Liu; Rosemarie Chirco; Rafael Fridman; Hyeong-Reh Choi Kim
Journal:  EMBO J       Date:  2006-08-17       Impact factor: 11.598

Review 2.  Matrix metalloproteinase inhibitors as therapy for inflammatory and vascular diseases.

Authors:  Jialiang Hu; Philippe E Van den Steen; Qing-Xiang A Sang; Ghislain Opdenakker
Journal:  Nat Rev Drug Discov       Date:  2007-06       Impact factor: 84.694

3.  Insights into the structure and domain flexibility of full-length pro-matrix metalloproteinase-9/gelatinase B.

Authors:  Gabriel Rosenblum; Philippe E Van den Steen; Sidney R Cohen; J Günter Grossmann; Jessica Frenkel; Rotem Sertchook; Nelle Slack; Richard W Strange; Ghislain Opdenakker; Irit Sagi
Journal:  Structure       Date:  2007-10       Impact factor: 5.006

Review 4.  Metalloproteinases and their natural inhibitors in inflammation and immunity.

Authors:  Rama Khokha; Aditya Murthy; Ashley Weiss
Journal:  Nat Rev Immunol       Date:  2013-09       Impact factor: 53.106

5.  A 17-residue sequence from the matrix metalloproteinase-9 (MMP-9) hemopexin domain binds α4β1 integrin and inhibits MMP-9-induced functions in chronic lymphocytic leukemia B cells.

Authors:  Estefanía Ugarte-Berzal; Elvira Bailón; Irene Amigo-Jiménez; Cidonia L Vituri; Mercedes Hernández del Cerro; María José Terol; Juan P Albar; Germán Rivas; José A García-Marco; Angeles García-Pardo
Journal:  J Biol Chem       Date:  2012-06-22       Impact factor: 5.157

6.  Chemical synthesis, purification and folding of the human monocyte chemotactic proteins MCP-2 and MCP-3 into biologically active chemokines.

Authors:  P Proost; P Van Leuven; A Wuyts; R Ebberink; G Opdenakker; J Van Damme
Journal:  Cytokine       Date:  1995-02       Impact factor: 3.861

7.  The hemopexin and O-glycosylated domains tune gelatinase B/MMP-9 bioavailability via inhibition and binding to cargo receptors.

Authors:  Philippe E Van den Steen; Ilse Van Aelst; Vibeke Hvidberg; Helene Piccard; Pierre Fiten; Christian Jacobsen; Soren K Moestrup; Simon Fry; Louise Royle; Mark R Wormald; Russell Wallis; Pauline M Rudd; Raymond A Dwek; Ghislain Opdenakker
Journal:  J Biol Chem       Date:  2006-05-03       Impact factor: 5.157

8.  Detailed structural analysis of N-glycans released from glycoproteins in SDS-PAGE gel bands using HPLC combined with exoglycosidase array digestions.

Authors:  Louise Royle; Catherine M Radcliffe; Raymond A Dwek; Pauline M Rudd
Journal:  Methods Mol Biol       Date:  2006

9.  Direct visualization of protease action on collagen triple helical structure.

Authors:  Gabriel Rosenblum; Philippe E Van den Steen; Sidney R Cohen; Arkady Bitler; David D Brand; Ghislain Opdenakker; Irit Sagi
Journal:  PLoS One       Date:  2010-06-16       Impact factor: 3.240

10.  Diffusion of MMPs on the surface of collagen fibrils: the mobile cell surface-collagen substratum interface.

Authors:  Ivan E Collier; Wesley Legant; Barry Marmer; Olga Lubman; Saveez Saffarian; Tetsuro Wakatsuki; Elliot Elson; Gregory I Goldberg
Journal:  PLoS One       Date:  2011-09-01       Impact factor: 3.240

View more
  20 in total

1.  Inhibition of MMP-9-dependent Degradation of Gelatin, but Not Other MMP-9 Substrates, by the MMP-9 Hemopexin Domain Blades 1 and 4.

Authors:  Estefanía Ugarte-Berzal; Jennifer Vandooren; Elvira Bailón; Ghislain Opdenakker; Angeles García-Pardo
Journal:  J Biol Chem       Date:  2016-04-04       Impact factor: 5.157

Review 2.  Metalloproteinases mediate diabetes-induced retinal neuropathy and vasculopathy.

Authors:  Ghislain Opdenakker; Ahmed Abu El-Asrar
Journal:  Cell Mol Life Sci       Date:  2019-06-10       Impact factor: 9.261

Review 3.  Glycosylation of matrix metalloproteases and tissue inhibitors: present state, challenges and opportunities.

Authors:  Lise Boon; Estefania Ugarte-Berzal; Jennifer Vandooren; Ghislain Opdenakker
Journal:  Biochem J       Date:  2016-06-01       Impact factor: 3.857

4.  CXCL4 and CXCL4L1 Differentially Affect Monocyte Survival and Dendritic Cell Differentiation and Phagocytosis.

Authors:  Mieke Gouwy; Pieter Ruytinx; Egle Radice; Federico Claudi; Katrien Van Raemdonck; Raffaella Bonecchi; Massimo Locati; Sofie Struyf
Journal:  PLoS One       Date:  2016-11-09       Impact factor: 3.240

5.  Differential inhibition of activity, activation and gene expression of MMP-9 in THP-1 cells by azithromycin and minocycline versus bortezomib: A comparative study.

Authors:  Jennifer Vandooren; Sofie Knoops; João L Aldinucci Buzzo; Lise Boon; Erik Martens; Ghislain Opdenakker; Elzbieta Kolaczkowska
Journal:  PLoS One       Date:  2017-04-03       Impact factor: 3.240

6.  IGF-IR cooperates with ERα to inhibit breast cancer cell aggressiveness by regulating the expression and localisation of ECM molecules.

Authors:  Nikolaos A Afratis; Panagiotis Bouris; Spyros S Skandalis; Hinke A Multhaupt; John R Couchman; Achilleas D Theocharis; Nikos K Karamanos
Journal:  Sci Rep       Date:  2017-01-12       Impact factor: 4.379

7.  Inhibition of MMP2-PEX by a novel ester of dihydroxy cinnamic and linoleic acid from the seagrass Cymodocea serrulata.

Authors:  V S Christina; R Lakshmi Sundaram; V Sivamurugan; D Thirumal Kumar; C D Mohanapriya; V L Shailaja; S P Thyagarajan; C George Priya Doss; K Mary Elizabeth Gnanambal
Journal:  Sci Rep       Date:  2021-06-01       Impact factor: 4.379

8.  Elevated Expression of Matrix Metalloproteinase-9 not Matrix Metalloproteinase-2 Contributes to Progression of Extracranial Arteriovenous Malformation.

Authors:  Ting Wei; Haihong Zhang; Neslihan Cetin; Emily Miller; Teri Moak; James Y Suen; Gresham T Richter
Journal:  Sci Rep       Date:  2016-04-14       Impact factor: 4.379

9.  Matrix Metalloproteinase-1 and Matrix Metalloproteinase-9 in the Aqueous Humor of Diabetic Macular Edema Patients.

Authors:  Jin-Woo Kwon; Jin A Choi; Donghyun Jee
Journal:  PLoS One       Date:  2016-07-28       Impact factor: 3.240

10.  Neutrophils and Activated Macrophages Control Mucosal Immunity by Proteolytic Cleavage of Antileukoproteinase.

Authors:  Jennifer Vandooren; Pieter Goeminne; Lise Boon; Estefania Ugarte-Berzal; Vasily Rybakin; Paul Proost; Ahmed M Abu El-Asrar; Ghislain Opdenakker
Journal:  Front Immunol       Date:  2018-05-28       Impact factor: 7.561

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.